Zacks Investment Research
04 Jun 2026, 15:46 UTC · 16w ago
Verdict
Headline leans bearish. We score ADCT −1.00 across three claims.
Score confirms the headline.
Leans bearish
From its wording — no explicit rating
−1.00strongly bearish
What the story claims
3 claims · scored −1 bearish … +1 bullish
ADC Therapeutics shares plunged 53.4% in after-hours trading following results from the LOTIS-5 study.
So whatA massive share price collapse reflects a severe loss of investor confidence in the company's valuation and future.
More negative than 99% of claims this week
Investors focused on safety findings in the LOTIS-5 study showing higher rates of serious adverse events, treatment discontinuations, and fatal adverse events in the Zynlonta experimental arm.
Continue reading
5 related stories
More negative than 94% of ticker scores this week
Scored by the NIS engine · methodology.
Top 2 movers · tap to explore
More negative than 99% of claims this week
The phase III LOTIS-5 study met its primary efficacy endpoint, showing a median progression-free survival of 6.1 months for Zynlonta plus Rituxan versus 4.7 months for the control group.
More positive than 66% of claims this week
Which stocks this story touches
More negative than 94% of ticker scores this week
Shares plunged over 50% due to safety concerns and fatal adverse events in a clinical study.
Near neutral — 92% of ticker scores this week are stronger
Mentioned as a partner in a study, but the primary market reaction was focused on ADCT's safety data.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Seeking Alpha
5h ago
−59.1%
Price agrees with the score
$1.26 vs $3.08 close before publication (Jun 3) · not market-adjusted
ADCT chart →
